Therefore, the CD19 marker should be routinely used in laboratory testing to distinguish whether such cells are B lymphocytes, classical erythroblasts, or immunosuppressive TER cells (whether they are CD45+ or not), especially under conditions of hypoxia or anemia. Here, PTPRC is linked to anemia.